JP2002540769A5 - - Google Patents

Download PDF

Info

Publication number
JP2002540769A5
JP2002540769A5 JP2000601031A JP2000601031A JP2002540769A5 JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5 JP 2000601031 A JP2000601031 A JP 2000601031A JP 2000601031 A JP2000601031 A JP 2000601031A JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
substantially purified
purified protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2000601031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002540769A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/004613 external-priority patent/WO2000050453A1/en
Publication of JP2002540769A publication Critical patent/JP2002540769A/ja
Publication of JP2002540769A5 publication Critical patent/JP2002540769A5/ja
Abandoned legal-status Critical Current

Links

JP2000601031A 1999-02-26 2000-02-24 プログラム細胞死の新規抑制剤 Abandoned JP2002540769A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12210499P 1999-02-26 1999-02-26
US60/122,104 1999-02-26
PCT/US2000/004613 WO2000050453A1 (en) 1999-02-26 2000-02-24 A novel inhibitor of programmed cell death

Publications (2)

Publication Number Publication Date
JP2002540769A JP2002540769A (ja) 2002-12-03
JP2002540769A5 true JP2002540769A5 (enExample) 2007-04-26

Family

ID=22400634

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000601031A Abandoned JP2002540769A (ja) 1999-02-26 2000-02-24 プログラム細胞死の新規抑制剤

Country Status (7)

Country Link
US (1) US6570002B1 (enExample)
EP (1) EP1161444A4 (enExample)
JP (1) JP2002540769A (enExample)
AU (1) AU760466B2 (enExample)
CA (1) CA2363621A1 (enExample)
MX (1) MXPA01008626A (enExample)
WO (1) WO2000050453A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100111928A1 (en) * 1997-05-23 2010-05-06 A & G Pharmaceutical, Inc. Methods and kits for diagnosis tumorgenicity
US20030215445A1 (en) 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
AU2002315534B2 (en) * 2001-07-10 2008-05-22 Biogen Idec Inc. Inhibition of apoptosis process and improvement of cell performance
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
AU2003901010A0 (en) * 2003-03-06 2003-03-20 Flinders Technologies Pty Ltd Apoptosis regulator
EP1644038A2 (en) * 2003-06-23 2006-04-12 A & G Pharmaceuticals, Inc. Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
WO2005011590A2 (en) * 2003-08-01 2005-02-10 A & G Pharmaceutical, Inc. Compositions and methods for restoring sensitivity to treatment with her2 antagonists
ES2358267T3 (es) 2004-03-15 2011-05-09 Sunesis Pharmaceuticals, Inc. Composición farmacéutica que comprende sns-595 y sus usos.
US8580814B2 (en) * 2006-04-03 2013-11-12 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
EP2354138A1 (en) 2006-06-12 2011-08-10 Sunesis Pharmaceuticals, Inc. Compounds and compositions for treatment of cancer
SI2049109T1 (sl) * 2006-08-02 2016-04-29 Sunesis Pharmaceuticals, Inc. Kombinirana uporaba(+)-1,4-dihidro-7-((3s,4s)-3-metoksi-4-(metilamino)- 1-pirolidinil)-4-okso-1-(2-tiazolil)-1,8-naftiridin-3-karboksilne kisline in citarabina (ara-c) za zdravljenje levkemije
EP2214662B1 (en) * 2007-10-22 2016-07-13 Sunesis Pharmaceuticals, Inc. (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination with gemcitabine for use in treating cancer
AU2016306694B2 (en) 2015-08-12 2021-03-11 Memorial Sloan-Kettering Cancer Center Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
US5646008A (en) 1993-06-22 1997-07-08 The Regent Of The University Of Michigan Vertebrate apoptosis gene: compositions and methods
US5622852A (en) 1994-10-31 1997-04-22 Washington University Bcl-x/Bcl-2 associated cell death regulator
US5539094A (en) 1993-11-12 1996-07-23 La Jolla Cancer Research Foundation DNA encoding Bcl-2-associated proteins
FI962247A7 (fi) 1993-11-30 1996-07-22 Lxr Biotechnology Inc Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät
US5858678A (en) 1994-08-02 1999-01-12 St. Louis University Apoptosis-regulating proteins
US5858715A (en) 1997-01-29 1999-01-12 Incyte Pharmaceuticals, Inc. Human apoptosis-associated protein

Similar Documents

Publication Publication Date Title
JP2003515323A5 (enExample)
JP2002519061A5 (enExample)
JP2006516098A5 (enExample)
JP2002540769A5 (enExample)
JP2002524024A5 (enExample)
JPH1072351A5 (enExample)
WO1998055508A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
JP2003525623A5 (enExample)
WO2002038592A3 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
JP2004532624A5 (enExample)
JP2004508843A5 (enExample)
CA2361987A1 (en) Goodpasture antigen binding protein
WO2002016617A3 (en) Myrosinase from brevicoryne brassicae
AU2002233424A1 (en) Peptides having affinity for the GP120 viral protein and use thereof
ATE370160T1 (de) Peptide mit affinität zu gp120, und ihre verwendungen
JP2006510360A5 (enExample)
DE60126602D1 (de) Neue collectine
JP2003245242A5 (enExample)
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
JP2001078180A5 (enExample)
JPH10210974A5 (enExample)
AU2002220924A1 (en) Antibodies, peptides, analogs and uses thereof
JPH1132773A5 (enExample)
CA2244928A1 (en) Dna coding for serine/threonine kinase
WO2000042063A3 (de) Peptide zur inhibierung von hbv-core-proteinen